View Older Stories View More Recent Stories

Apr 18, 2016 07:42AM Biogen (BIIB) Says TECFIDERA Data Confirms Efficacy in Newly Diagnosed MS Patients
Apr 18, 2016 07:30AM TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World Effectiveness
Apr 14, 2016 08:00AM Biogen Joins in Celebration of World Hemophilia Day
Apr 12, 2016 07:30AM Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
Apr 1, 2016 11:31AM Biogen (BIIB) Announces Receipt of Positive CHMP Opinion for FLIXABI
Apr 1, 2016 11:30AM FLIXABI®, an Infliximab Biosimilar Candidate Referencing Remicade®, Receives Positive CHMP Opinion
Mar 30, 2016 08:01AM Biogen (BIIB) Names Michel Vounatsos EVP, Chief Commercial Officer
Mar 30, 2016 08:00AM Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer
Mar 28, 2016 04:01PM Biogen to Present at the Goldman Sachs Alzheimer’s Symposium
Mar 21, 2016 04:01PM Biogen to Report First Quarter 2016 Financial Results on April 21, 2016
Mar 8, 2016 07:00AM Flex Pharma Reports Year End 2015 Financial Results
Feb 29, 2016 04:01PM Biogen to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 26, 2016 07:17AM Biogen (BIIB) Announces Positive Opinion from CHMP for Alprolix for Treatment of Haemophilia B
Feb 26, 2016 07:14AM Sobi and Biogen receive positive opinion from CHMP for Alprolix® (rFIXFc) for the treatment of haemophilia B
Feb 26, 2016 07:11AM Sobi and Biogen Receive Positive Opinion from CHMP for Alprolix® (rFIXFc) for the Treatment of Hemophilia B
Feb 8, 2016 07:00AM Biogen Joins Pioneering Target Validation Collaboration
Feb 4, 2016 04:01PM Biogen to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Jan 16, 2016 09:05PM BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in the European Union
Dec 8, 2015 07:02AM Biogen (BIIB), Sobi Present Positive Data on ELOCTATE, ALPROLIX in Hemophilia A and B
Dec 8, 2015 07:00AM New Data Show ELOCTATE® and ALPROLIX® May Help Control Target Joint Bleeds in People with Hemophilia A and B
Nov 24, 2015 02:00AM Sobi and Biogen’s ELOCTA® (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
Nov 20, 2015 07:15AM Biogen Announces Benepali™ (Etanercept) is the First Biosimilar of Enbrel® to Receive a Positive Opinion from CHMP
Oct 26, 2015 11:46AM With global outlook weak, many U.S. companies tighten belts
Oct 21, 2015 05:28PM Market Wrap: Citron Slams Valeant; Biden Pulls Out of Presidential Race; Twitter Clipps on Downgrade
Oct 21, 2015 09:27AM Pre-Open Stock Movers 10/21: (KLAC) (ISRG) (SNDK) Higher; (SNTA) (VMW) (TWTR) Lower (more...)
Oct 9, 2015 08:46PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Biogen Inc. and Advises Shareholders with Losses to Contact the Firm
Oct 8, 2015 06:15AM Results from ZINBRYTA™ (Daclizumab High-Yield Process) Phase 3 DECIDE Study Highlighting Efficacy Compared to Interferon Beta-1a Published in the New England Journal of Medicine and Presented at ECT
Sep 21, 2015 03:42PM Hillary Clinton All Bark, No Bite with Biotech Tweet
Sep 21, 2015 12:35PM Biotechs Pressured Following Clinton Tweet (IBB)
Sep 14, 2015 02:00AM PureTech Appoints Michael MacLean as Chief Financial Officer
Aug 11, 2015 10:19AM Notable Analyst Rating Changes 8/11: (ADBE) (RAX) (VZ) Upgraded; (AMAT) (KMT) (XON) Downgraded
Aug 5, 2015 07:30AM Flex Pharma Reports Second Quarter 2015 Financial Results
Jun 18, 2015 08:00AM Biogen and SELF Help Women Reimagine Daily Life with Relapsing Multiple Sclerosis (RMS)
Jun 15, 2015 08:30AM Alfred Sandrock, Jr., M.D., Ph.D., Chief Medical Officer of Biogen, Joins Flex Pharma’s Scientific Advisory Board
May 7, 2015 10:00AM Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell
May 7, 2015 10:00AM Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell
Apr 29, 2015 07:30AM FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Apr 16, 2015 09:00AM Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day
Mar 27, 2015 07:00AM European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Jul 15, 2014 10:25AM Social Media/Biotech Stocks React as Yellen Says Valuations 'Appear Substantially Stretched'
May 19, 2014 08:05AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
Apr 15, 2014 10:41AM Stocks Choppy With Escalation of Ukraine Violence
Apr 10, 2014 01:57PM Stocks Sink; Margin Fears Take Center Stage
Apr 4, 2014 12:37PM Blood-Bath in Nasdaq Stocks
Jan 8, 2014 10:38AM Notable Analyst Rating Changes 01/08: (RAD) (PNRA) (FLIR) Upgraded; (AMBA) (TWTR) (TCS) Downgraded
Nov 25, 2013 01:51PM Notable 52-Week Highs and Lows of the Day 11/25: (WMT) (RAD) (CBST) High; (EBAY) (TWTR) Low
Jul 26, 2010 01:01PM Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
View More Recent Stories View Older Stories